1,7-Diaza-spiro[3.5]nonane-7-carboxylic acid tert-butyl ester hydrochloride

Catalog No.: 
ACLFWS413
CAS No.: 
1955492-91-7
Molecular Formula: 
C12H23ClN2O2
Molecular Weight: 
262.78
1,7-Diaza-spiro[3.5]nonane-7-carboxylic acid tert-butyl ester hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$166.00InquiryInquiry
250mg95%$221.00InquiryInquiry
500mg95%$370.00InquiryInquiry
1g95%$555.00InquiryInquiry
5g95%$1761.00InquiryInquiry
10g95%$3125.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,7-Diaza-spiro[3.5]nonane-7-carboxylic acid tert-butyl ester hydrochloride
IUPAC Nametert-butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate hydrochloride
MDL No.MFCD26954753
Molecular FormulaC12H23ClN2O2
Molecular Weight262.78
SMILESO=C(N(CC1)CCC21CCN2)OC(C)(C)C.[H]Cl
InChI KeyPQRWJSXZTMGGEX-UHFFFAOYSA-N
SynonymMFCD26954753 | tert-butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate;hydrochloride | 1,7-Diaza-spiro[3.5]nonane-7-carboxylicacidtert-butylesterhydrochloride | E79979 | 1,7-Diaza-spiro[3.5]nonane-7-carboxylic acid t-butyl ester hydrochloride | SCHEMBL17848752
CAS No.1955492-91-7
PubChem CID86767488

Synthetic Route by SureRoute

1. ACLFWS413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLFWS413 route product structure diagram
    ACLFWS4131955492-91-7
Inquiry

2. ACLFWS413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLFWS413 route product structure diagram
    ACLFWS4131955492-91-7
Inquiry

3. ACLFWS413 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLFWS413 route product structure diagram
    ACLFWS4131955492-91-7
Inquiry

Comments (0)